Filing Details
- Accession Number:
- 0001209191-22-008061
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-02-09 17:00:20
- Reporting Period:
- 2022-02-07
- Accepted Time:
- 2022-02-09 17:00:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1658247 | Crinetics Pharmaceuticals Inc. | CRNX | Pharmaceutical Preparations (2834) | 263744114 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1807856 | Ajay Madan | C/O Crinetics Pharmaceuticals, Inc. 10222 Barnes Canyon Road, Bldg 2 San Diego CA 92121 | Chief Development Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-02-07 | 13,411 | $17.83 | 172,045 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person at least 30 days prior to the trading date.
- Represents the weighted average sale price for the entire number of shares sold. The actual sales prices range between $17.170 and $18.015. Detailed information on the exact number of shares sold at each sale price can be obtained from the issuer upon request.